Third Security’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,562
Closed -$2.65M 15
2020
Q3
$2.65M Hold
2,562
0.55% 5
2020
Q2
$3.2M Hold
2,562
0.53% 7
2020
Q1
$2.67M Buy
2,562
+1,702
+198% +$1.64M 0.57% 7
2019
Q4
$809K Hold
860
0.13% 9
2019
Q3
$836K Hold
860
0.13% 10
2019
Q2
$759K Hold
860
0.09% 10
2019
Q1
$906K Hold
860
0.14% 10
2018
Q4
$1.33M Hold
860
0.18% 11
2018
Q3
$1.78M Hold
860
0.12% 12
2018
Q2
$2.14M Hold
860
0.17% 13
2018
Q1
$2.69M Hold
860
0.2% 13
2017
Q4
$3.64M Hold
860
0.31% 12
2017
Q3
$6.5M Hold
860
0.41% 9
2017
Q2
$5.73M Hold
860
0.29% 10
2017
Q1
$6.8M Hold
860
0.4% 10
2016
Q4
$8.36M Hold
860
0.45% 8
2016
Q3
$7.12M Hold
860
0.33% 10
2016
Q2
$7.89M Buy
860
+126
+17% +$1.69M 0.41% 10
2016
Q1
$11.9M Hold
734
0.47% 8
2015
Q4
$19.8M Buy
734
+187
+34% +$4.67M 0.79% 7
2015
Q3
$16.1M Hold
547
0.64% 7
2015
Q2
$13.5M Hold
547
0.35% 9
2015
Q1
$10M Hold
547
0.28% 12
2014
Q4
$8.76M Hold
547
0.4% 12
2014
Q3
$12.3M Hold
547
0.77% 9
2014
Q2
$19.2M Hold
547
0.91% 10
2014
Q1
$28.2M Hold
547
1.25% 7
2013
Q4
$27.6M Buy
547
+108
+25% +$5.64M 1.32% 6
2013
Q3
$23.7M Buy
439
+147
+50% +$8.21M 1.2% 7
2013
Q2
$16.3M Buy
+292
New +$16.5M 3.89% 8

Other funds holding OGEN

Third Security's OGEN Position: Q4 2020 in Review

Third Security sold out of Oragenics (OGEN) in Q4 2020, closing a stake of 2,562 shares — an estimated $2.65M sold.

Third Security first reported a position in OGEN in Q2 2013 and held it in 30 quarters. The position peaked at $28.2M in Q1 2014. 20 funds tracked by Wall St. Rank hold OGEN as of Q4 2020.

  • Third Security reported no remaining Oragenics position as of Q4 2020 after selling out during the quarter.
  • Third Security sold 2,562 Oragenics shares in Q4 2020, an estimated $2.65M.
  • Third Security first reported a position in Oragenics in Q2 2013 and held it in 30 quarters.
  • Third Security's Oragenics position peaked at $28.2M in Q1 2014.
  • 20 funds tracked by Wall St. Rank held Oragenics as of Q4 2020.

Based on Third Security's 13F filing for Q4 2020, filed 16 Feb 2021.